Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report

Drug-induced immune haemolytic anaemia (DIIHA) is extremely rare. We herein report a case of DIIHA due to co-amoxiclav. A 53-year-old male being treated for left-sided pyelonephritis with intravenous co-amoxiclav developed symptoms and signs of anaemia on the third day of treatment. He was found to...

Full description

Saved in:
Bibliographic Details
Main Authors: H. G. C. S. Karunathilaka, D. P. Chandrasiri, P. Ranasinghe, V. Ratnamalala, A. H. N. Fernando
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2020/9841097
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560661567111168
author H. G. C. S. Karunathilaka
D. P. Chandrasiri
P. Ranasinghe
V. Ratnamalala
A. H. N. Fernando
author_facet H. G. C. S. Karunathilaka
D. P. Chandrasiri
P. Ranasinghe
V. Ratnamalala
A. H. N. Fernando
author_sort H. G. C. S. Karunathilaka
collection DOAJ
description Drug-induced immune haemolytic anaemia (DIIHA) is extremely rare. We herein report a case of DIIHA due to co-amoxiclav. A 53-year-old male being treated for left-sided pyelonephritis with intravenous co-amoxiclav developed symptoms and signs of anaemia on the third day of treatment. He was found to have evidence of haemolysis with a positive Coombs test and IgG antibodies and C3d. Co-amoxiclav was identified as the probable culprit, using the Naranjo adverse drug reaction probability scale. Upon discontinuation of the drug and blood transfusion, the patient’s haematological parameters stabilised. Steroids were not required in the treatment. Diagnosis of DIIHA is made through a history of intake of co-amoxiclav, clinical and laboratory features of haemolysis, and a positive Coombs test. An autoantibody screen is most commonly negative. It is essential for clinicians to be aware about this rare complication caused by commonly prescribed drugs and be able to accurately diagnose and initiate treatment.
format Article
id doaj-art-46fc03ae4ca0430a8a323c6bc5bdfa50
institution Kabale University
issn 2090-6560
2090-6579
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-46fc03ae4ca0430a8a323c6bc5bdfa502025-02-03T01:27:04ZengWileyCase Reports in Hematology2090-65602090-65792020-01-01202010.1155/2020/98410979841097Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case ReportH. G. C. S. Karunathilaka0D. P. Chandrasiri1P. Ranasinghe2V. Ratnamalala3A. H. N. Fernando4National Hospital of Sri Lanka, Colombo, Sri LankaNational Hospital of Sri Lanka, Colombo, Sri LankaDepartment of Pharmacology, Faculty of Medicine, University of Colombo, Colombo, Sri LankaNational Hospital of Sri Lanka, Colombo, Sri LankaNational Hospital of Sri Lanka, Colombo, Sri LankaDrug-induced immune haemolytic anaemia (DIIHA) is extremely rare. We herein report a case of DIIHA due to co-amoxiclav. A 53-year-old male being treated for left-sided pyelonephritis with intravenous co-amoxiclav developed symptoms and signs of anaemia on the third day of treatment. He was found to have evidence of haemolysis with a positive Coombs test and IgG antibodies and C3d. Co-amoxiclav was identified as the probable culprit, using the Naranjo adverse drug reaction probability scale. Upon discontinuation of the drug and blood transfusion, the patient’s haematological parameters stabilised. Steroids were not required in the treatment. Diagnosis of DIIHA is made through a history of intake of co-amoxiclav, clinical and laboratory features of haemolysis, and a positive Coombs test. An autoantibody screen is most commonly negative. It is essential for clinicians to be aware about this rare complication caused by commonly prescribed drugs and be able to accurately diagnose and initiate treatment.http://dx.doi.org/10.1155/2020/9841097
spellingShingle H. G. C. S. Karunathilaka
D. P. Chandrasiri
P. Ranasinghe
V. Ratnamalala
A. H. N. Fernando
Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report
Case Reports in Hematology
title Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report
title_full Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report
title_fullStr Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report
title_full_unstemmed Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report
title_short Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report
title_sort co amoxiclav induced immune haemolytic anaemia a case report
url http://dx.doi.org/10.1155/2020/9841097
work_keys_str_mv AT hgcskarunathilaka coamoxiclavinducedimmunehaemolyticanaemiaacasereport
AT dpchandrasiri coamoxiclavinducedimmunehaemolyticanaemiaacasereport
AT pranasinghe coamoxiclavinducedimmunehaemolyticanaemiaacasereport
AT vratnamalala coamoxiclavinducedimmunehaemolyticanaemiaacasereport
AT ahnfernando coamoxiclavinducedimmunehaemolyticanaemiaacasereport